Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 2012. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) in the company's Ordinary shares, rather than a comprehensive financial results report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific executive compensation event.
Material Changes
The material change disclosed is the vesting of 25% of a Deferred Investment Award Plan made on December 18, 2006, for Mr. C Weber. This event resulted in a cash payment entitlement of 1359.25p per share for 6,525.550 notional Ordinary shares, scheduled for payment on January 18, 2013.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a regulatory disclosure required under Disclosure and Transparency Rule 3.1.4R(1)(a).
Investor Verification Points
- Verify the total cash payout amount for Mr. C Weber based on the 1359.25p per share rate and 6,525.550 notional shares.
- Confirm the payment date of January 18, 2013, for the vested award.
- Note that this filing does not contain quarterly or annual financial performance data.